Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Six pharma stocks that should be on your radar today over various news triggers
It was a busy weekend for pharma stocks as four of them — Divi's Laboratories, Fortis Healthcare, Torrent Pharma and Narayana Hrudayalaya — reported their quarterly results. Meanwhile, Lupin marked its entry into the Chinese market, while Glenmark Pharma's US arm settled an anti-trust litigation. Here's a look at these names in detail:
India Inc's foreign investments more than double in April
Indian companies significantly boosted overseas investments in April. Direct investments surged to $3.37 billion, more than doubling from March. Equity investments led this growth. Coforge was a major investor, with other companies like Lupin and Wingify Software also making substantial commitments. These investments spanned various sectors and regions, indicating active global expansion by Indian businesses.
India Inc's foreign investments more than double in April
Indian companies significantly boosted overseas investments in April. Direct investments surged to $3.37 billion, more than doubling from March. Equity investments led this growth. Coforge was a major investor, with other companies like Lupin and Wingify Software also making substantial commitments. These investments spanned various sectors and regions, indicating active global expansion by Indian businesses.
Stocks to watch: BEL, IOC, Lupin among 10 shares in focus today; check list here
Stock market today: The Indian stock market is likely to continue its gaining streak as trends in the Gift Nifty index signalled a positive opening on Tuesday. Amid this backdrop, these stocks will remain in focus on 19 May.
Lupin receives US FDA tentative approval for Revefenacin inhalation solution
Shares of Lupin Ltd ended at ₹2,248.00, down by ₹25.90, or 1.14%, on the BSE.
Lupin gets FDA nod for famotidine injection to treat ulcers, GERD
The product is bioequivalent to the reference listed drug (RLD), Pepcid injection, 10 mg/mL, manufactured by Merck Sharp & Dohme Corp. Shares of Lupin Ltd ended at ₹2,215.45, down by ₹30.55, or 1.36%, on the BSE today, May 13.
Rajesh Palviya of Axis Sec suggests NBCC, Lupin, RBL Bank shares to buy today - 8 May - Mint
Rajesh Palviya of Axis Sec suggests NBCC, Lupin, RBL Bank shares to buy today - 8 MayMint
Lupin Shares Slump Despite 90% Jump In Q4 Profit, Highest-Ever Dividend Announcement
Of the 40 analysts tracing the stock as per Bloomberg data, Lupin has 'buy' calls from 28 of them. The stock also has eight 'hold' calls, and four 'sell' calls.
Stock Alert: Sonata Software, Bombay Stock Exchange, Dabur India, Lupin, Blue Star, NOCIL - Business Standard
Stock Alert: Sonata Software, Bombay Stock Exchange, Dabur India, Lupin, Blue Star, NOCILBusiness Standard
Stocks To Watch Today: Dabur, Britannia Industries, BSE, Mahnagar Gas, Lupin, Titan, SBI, Swiggy, MCX & More
Here's a look at stocks that are likely to be in focus during the trading session on Friday.
Lupin Q4 Results: Profit Soars 90%, Revenue Nears Rs 7,500 Crore; Highest-Ever Dividend Declared
Consolidated revenue of Lupin advanced by 31.9% year-on-year for the three months ended March, reaching Rs 7,475 crore in comparison to Rs 5,667 crore.
Q4 Results LIVE Updates: Bajaj Auto reacts to earnings beat, buyback; Lupin, Biocon report today
Q4 Results LIVE Updates: Bajaj Auto reacts to results, along with platform stocks Meesho, Paytm and PB Fintech. Britannia, Lupin, Biocon, Bharat Forge among eight F&O names report results today. Watch this space for all the LIVE updates.